Advertising Disclaimer
Published online May 1, 2006
PEDIATRICS Vol. 117 No. 5 May 2006, pp. e887-e893 (doi:10.1542/peds.2005-1064)
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uus, K.
Right arrow Articles by Bamford, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uus, K.
Right arrow Articles by Bamford, J.
Related Collections
Right arrow Dentistry & Otolaryngology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effectiveness of Population-Based Newborn Hearing Screening in England: Ages of Interventions and Profile of Cases

Kai Uus, MD, PhD, John Bamford, PhD

Audiology and Deafness Research Group, School of Psychological Sciences, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom


    ABSTRACT
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
OBJECTIVE. The objective of this study was to determine the effectiveness in routine practice of the first phase of a national population-based newborn hearing screening and follow-up program that seeks to identify infants with bilateral permanent hearing loss of ≥40-dB hearing loss.

METHODS. The study was a part of the independent evaluation of the 23 first phase sites (annual birth population ~120000) of the national newborn hearing screening program in England. For each infant identified with the defined hearing loss, the measures of interest were degree and type of hearing loss, presence of risk factors, age of first audiologic assessment, age of identification of hearing loss, age of enrollment in an early support program, and age of hearing aid fitting. Data collection took place over the first 2 years of the program.

RESULTS. Data were provided on 169 infants with permanent bilateral moderate or greater hearing loss identified through screening 169487 infants. Fifty-four percent of all cases were from an "at-risk" population. Three fourths of these "at-risk" infants spent ≥48 hours in the NICU. For the whole sample, the median age at first audiologic assessment was 5 weeks; the median age of identification of the hearing loss and of enrollment in early support program was 10 weeks irrespective of the degree of hearing loss; and the median age at hearing aid fitting was 16 weeks. Infants with moderate hearing loss were fitted with hearing aids significantly later than those with severe and profound hearing loss.

CONCLUSIONS. Properly implemented, a newborn hearing screening program based on whole populations and routine service provision can deliver satisfactory outcomes in terms of age of referral, identification, and intervention. The distribution of degree and type of hearing loss and proportion with risk factors was similar to that expected. The numbers identified were such as to suggest that very few cases were missed by the screening program.


Key Words: newborn hearing screening • risk factors • age at identification • age at hearing aid fitting

Abbreviations: NHSP—newborn hearing screening program • CI—confidence interval • OAE—otoacoustic emission • ABR—auditory brainstem response • WIN—well-infant nursery • IQR—interquartile range

Permanent congenital bilateral hearing loss of moderate or greater degree is rare, with a prevalence of around 1 per 1000 births.1 However, there is evidence that the impact of such hearing loss on the development of language and communication can be substantial unless effective intervention is started within the first year of life, preferably before 6 months of age.2 Language development is positively and significantly affected by the age of identification of the hearing loss and age of initiation into intervention services. Although there remains some debate about the weight of evidence with regard to the effect of early intervention on language development, largely because of study design issues,3 there are also cogent arguments for early identification and intervention that derive from ethical principles.4 Before universal newborn hearing screening, the average age of identification of congenital permanent hearing loss was around 2 years in the United Kingdom, continental Europe, and North America,58 and the median age of hearing aid fitting was delayed on average for another 6 months.5

After a systematic review by Davis et al,9 the Department of Health in England commissioned a national population-based newborn hearing screening program (NHSP) in 2001. It is anticipated that all areas of England will participate in the program by late 2005. Simultaneously, an independent evaluation of the first phase of the screen sites spread around the country covering ~120000 births per annum was commissioned. The evaluation showed an overall coverage of 96%, a mean referral rate of just below 3% (unilateral and bilateral referrals combined), a lost-to-follow-up rate of approximately 10%, and a yield for bilateral moderate or greater permanent hearing loss of 1.00 (95% confidence interval [CI] 0.78–1.22) per 1000 screened (NHSP Evaluation Team, unpublished data); the yield is in line with the reported prevalence rate in England.5

Newborn hearing screening is merely the first step in comprehensive early hearing detection and intervention programs. To demonstrate effectiveness, a screening program requires that the services be in place to provide authoritative follow-up and appropriate intervention.10 The aim of this part of the evaluation was to extend the data collection and analyses to the follow-up of infants referred by the screen to additional determine the effectiveness of the screen in routine practice. The number and type of hearing losses identified, the proportion with risk factors, and the ages of first audiologic assessment, identification, enrollment in early support program, and hearing aid fitting were chosen as the outcome measures.


    METHODS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
The details of the screening protocol and screening sites are reported elsewhere.11 Briefly, the NHSP implementation uses 2 screen protocols, 1 for well infants and 1 for infants who have been in a NICU for ≥48 hours. Both protocols involve 2 test procedures within the one screen. In the former, representing the great majority of screenings, well infants are tested using transient evoked automated otoacoustic emissions (OAEs) first and, if there is no clear emission in either ear, they undergo automated auditory brainstem response (ABR) testing. Thus, for well infants, the ABR test is contingent on the lack of clear OAE responses. For NICU infants, both OAE and ABR are used, with a screen refer if a clear response is missing on either (again, in either ear).

Procedure
Documentation for data collection was sent to the screening management teams of the 23 first phase NHSP sites shortly after each site had started the screening program. The documentation consisted of a detailed instruction chart and 4 Proformas that the screening team leader was instructed to send to the pediatric audiology follow-up service(s) in their area. Three of the Proformas were completed by the pediatric audiology service and returned directly to the evaluation team. These Proformas were anonymized, displaying only the child's local unique identifier and date of birth, and giving information on the 4 main measures (ages at first audiologic assessment, identification, enrollment in early support program, and hearing aid fitting), as well as gender, the degree and type of hearing loss, and presence of risk factors. The fourth Proforma, detailing the name, address, and local unique identifier of each true case, was sent by pediatric audiology services to the screening team leaders and retained by them.

Data were collected for all children born between the start of the screening program (variable across sites) and January 1, 2004, who were identified with permanent bilateral moderate or greater hearing loss (estimated ≥40-dB hearing loss averaged over 0.5, 1, 2, and 4 kHz in the better hearing ear). During this period, 169487 infants were screened in the first phase NHSP sites that were spread all over England. Follow-up of referrals was undertaken by local pediatric audiology departments working to preferred practice guidelines.12

Measures
Age at first audiologic follow-up is the chronologic age of the infant at the first audiologic follow-up assessment after a "screen-refer" decision. The data presented here are based only on the subjects who were eventually identified with hearing loss.

Age at identification is the chronologic age of the infant when, using age-appropriate assessments, there is good clinical evidence to suggest that the infant has a permanent bilateral moderate or greater hearing loss. At this stage, the exact degree and configuration of the hearing loss may still remain uncertain.

Age at enrollment in early support program is the chronologic age of the infant when they are referred to the specialist education services that provide the programs.

Age at hearing aid fitting is the chronologic age of the infant at the first hearing aid fitting.

Data Analysis
Analyses were conducted by using SPSS 11.5 for Windows (SPSS Inc, Chicago, IL). The main analyses consisted of 1-way analysis of variance comparing the measures for different degrees of hearing loss. Independent t tests were conducted to compare measures for different types of nursery (well-infant nursery [WIN] versus NICU).


    RESULTS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
The number of cases that the evaluation team was informed of was 169. Considerable effort was put into reminding services to pass the information on cases to the evaluation team, and this figure is likely to be close to the "true" number identified. It gives a yield figure per thousand screened infants, which is close to published prevalence figures for congenital bilateral permanent hearing loss of moderate or greater degree.1,5 Of course, some cases may still have not been identified as a result of, for example, assessment difficulties with mild to moderate losses or temporary conductive hearing loss overlay, nonattendance at follow-up, and so on (NHSP Evaluation Team, unpublished data). Nevertheless, the data presented in this section are likely to be robust and close to the "true" situation.

Profile of Cases
Tables 1 through 3 provide the basic information on the profile of the 169 infants identified with permanent bilateral hearing loss. Fifty-seven percent of the subjects were male and 43% were female.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Distribution of Type of Hearing Loss

 

View this table:
[in this window]
[in a new window]
 
TABLE 2 Distribution of Risk Factors in 91 High-Risk Infants Identified With Permanent Bilateral Hearing Loss

 

View this table:
[in this window]
[in a new window]
 
TABLE 3 Distribution of Degree of Hearing Loss Based on Better Hearing Ear (n = 152)

 
As expected, sensorineural hearing loss was the most predominant type of hearing loss (Table 1). Auditory dyssynchrony was defined as a condition characterized by the absence or severe abnormality of ABR in the presence of OAEs and was reported in 17 cases. Fifty-four percent of the infants had identifiable risk factors. Table 2 details the distribution of risk indicators for these 91 infants. The most common indicator was spending ≥48 hours in the NICU occasionally combined with a family history of childhood hearing loss, craniofacial anomaly, or both; 75.8% (N = 69) of high-risk infants were from the NICU population.

For the following analyses, subjects with auditory neuropathy have been excluded. Table 3 provides details of the distribution of degree of hearing loss (4-frequency average: moderate hearing loss 40–69-dB hearing loss; severe hearing loss 70–94-dB hearing loss, and profound hearing loss ≥95-dB hearing loss).

Age at the First Audiologic Follow-up Assessment
Median age at the first follow-up appointment after screen referral was 5 weeks. Independent t tests showed a significant difference in the age at the first audiologic follow-up assessment between infants from the WIN and the NICU (t = 6.516; degrees of freedom = 139; P < .001), with the median age for WIN infants being 4 weeks (interquartile range [IQR] 3–10 weeks) compared with 9 weeks (IQR: 4.5–17 weeks) for NICU infants.

Table 4 details the descriptive statistics of the age at the first audiologic follow-up appointment for different degrees of hearing loss. Posthoc testing using the Tukey B test indicated that there was no significant difference in age at first follow-up between the different hearing loss groups (F[2,130] = 2.641; P = .075). When the data from the NICU population were analyzed separately, the Tukey B test revealed a significant difference in age of first follow-up appointment between infants who were eventually identified with different degrees of hearing loss (F[2,58] = 4.132; P = .021): infants with profound hearing loss fall into a separate subset for {alpha} = .05, that is, were followed up significantly later.


View this table:
[in this window]
[in a new window]
 
TABLE 4 Descriptive Statistics for Age at First Audiologic Assessment

 
Table 5 gives details of the reasons for the delay for the first audiologic follow-up for WIN infants who emerged as statistical outliers. In NICU infants, the delay in attending first audiologic follow-up was without exception to do with the health of the infant.


View this table:
[in this window]
[in a new window]
 
TABLE 5 Descriptive Statistics for Age at Identification of Hearing Loss (separately for WIN and NICU population)

 
Age at Identification of Hearing Loss
Median age for identification of hearing loss was 10 weeks. Independent t tests showed a significant difference in the identification age between infants from WIN and NICU (t = 2.638; degrees of freedom = 148; P = .009), with the median age for WIN infants being 10 weeks (IQR: 4–13 weeks) compared with 13 weeks (IQR: 8.3–21 weeks) for NICU infants.

Table 6 shows the descriptive statistics of age at identification of hearing loss by degrees of hearing loss. Tukey B test indicated that there were no significant differences in identification age between the hearing loss groups (F[2,130] = .046; P = .955).


View this table:
[in this window]
[in a new window]
 
TABLE 6 Details of Reasons for Delay of the First Audiologic Follow-up Assessment (WIN Population)

 
Age at Enrollment in Early Support Programs
Median age for referral to education services, which in the United Kingdom provide the most common source of early support programs for families, was 10 weeks (IQR: 5–19 weeks).

Table 7 shows the age of enrollment to early support programs by degree of hearing loss. Tukey B tests indicated that there were no significant differences in age between the groups (F[2,138] = 1.039; P = .357).


View this table:
[in this window]
[in a new window]
 
TABLE 7 Descriptive Statistics for Age Referral to Early Support Program

 
Age at Hearing Aid Fitting
Median age at hearing aid fitting was 16 weeks, with the median age for WIN infants being 14 weeks (IQR: 8–21 weeks) compared with 24 weeks (IQR: 13–32 weeks) for NICU infants.

The median delay from identification of hearing loss to hearing aid fitting was 5 weeks.

Table 8 shows the age of hearing aid fitting by degree of hearing loss. Tukey B tests indicated that there was a significant difference between the groups (F[2,130] = 8.667; P < .001); infants with moderate hearing loss were fitted with hearing aids significantly later and fall into a separate subset for {alpha} = .05.


View this table:
[in this window]
[in a new window]
 
TABLE 8 Descriptive Statistics for Hearing Aid Fitting

 
In 15 cases (9.9% of the cohort), the decision was made not to fit hearing aids by the time of reporting: 7 moderate, 2 severe, and 6 profound hearing losses. For all these cases, the decision was made on the basis of parental choice.

Figure 1 presents the cumulative distributions for the 4 outcome measures used in these analyses: age at first follow-up appointment, age at identification of hearing loss, age at enrollment in early support program, and age of hearing aid fitting.


Figure 1
View larger version (18K):
[in this window]
[in a new window]
 
FIGURE 1 Summary of cumulative percentage for chronologic age at the main events: first follow-up appointment (first), identification of hearing loss (ID), enrollment in early support program (Edu), and hearing aid fitting (HA).

 

    DISCUSSION
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
Median age at the first audiologic follow-up for infants subsequently identified as having a bilateral hearing loss was 5 weeks of chronologic age. Infants from the WIN tended to be followed up earlier. Infants from the NICU are often too ill and may have serious health problems that take immediate priority over possible hearing problems. Infants from the NICU who will eventually be identified with profound hearing loss are followed up significantly later than infants who have lesser degrees of hearing loss, probably because these infants are most severely ill.

The reasons for exceptional delays to follow-up were different in WIN infants and NICU infants. In NICU infants, these were related to the infant's health and long hospitalization. In WIN infants, the reasons were service-related, mainly resulting from long waiting times for audiologic assessments and administrative slipups.

The newborn screening program first phase sites identified and informed the evaluation team of 169 infants with bilateral permanent hearing loss between their starting date (staggered from December 2001 to September 2002) and January 1, 2004. The yield for the period was 1.0 per 1000 infants screened, which is close to expected figures based on prevalence data (eg, 1.12 per 1000 from Fortnum and Davis5).

It is important to emphasize that the yield figure is significantly lower than demonstrated by most Northern American programs because the target case for the newborn hearing screening in England does not include unilateral or mild hearing loss. The report by Davis et al9 concluded that there was a strong case to be made for a universal newborn hearing screen to identify bilateral permanent hearing loss of ≥40-dB hearing loss. Davis et al9 argued that although there was no denying the effects of mild or unilateral permanent congenital hearing loss on speech perception in noisy backgrounds and on various aspects of educational achievement, mild or unilateral hearing loss did not constitute serious public health hazard; there was no unequivocal evidence of effectiveness, particularly cost-effectiveness, of screening for these conditions at birth; and there was no robust evidence about whether intervention would be effective. Unilateral test/screen fails are retested and referred to increase the sensitivity of the screen, not to specifically identify unilateral hearing loss. As expected, some cases of unilateral hearing loss as well as mild hearing loss are nevertheless detected by the screen. Evidence-based guidelines for management of unilateral and mild hearing loss are urgently needed in England.

The distribution of degree of hearing loss is somewhat different from previous studies. Fortnum and Davis5 found that moderate hearing loss was more prevalent than severe and profound hearing loss put together. In the present cohort, profound hearing loss was more common than expected. It should be noted that the category of hearing loss for any particular child was determined in the early stages of the assessment/diagnostic procedures, and that these may change as more accurate information emerges. On the other hand, if preferred practice guidelines for assessment are followed properly (see www.nhsp.info),12 then accurate assessment should be possible by 6 months of age in most cases; furthermore, in all cases, the clinicians maintained the reported degree of hearing loss when they fitted the hearing aids, suggesting a high degree of certainty about degree of loss. Thus, the reasons for the somewhat different distribution of degrees of hearing loss in the current cohort are unclear; assessment difficulties for moderate hearing loss may play a part, but a secular trend for an increase in the proportion of profound hearing losses (eg, in the increasing population of NICU infants) is also a real possibility. Such a possibility will be confirmed, or not, as the newborn screening program rolls out and the number of true cases increases.

Not surprisingly, sensorineural hearing loss was the most common type of hearing loss. Approximately 10% of the cohort of true cases were identified with auditory neuropathy; this is in line with other studies.13,14 All infants identified with auditory neuropathy were from the NICU population as a result of the protocol adopted for NICU infants; any cases from the WIN population (thought to be a much lower prevalence) will have to emerge over time.

Risk factors for permanent congenital hearing loss are well established. The 3 major risk factors are (1) a history of admission to NICU for >48 hours, (2) a family history of early childhood permanent deafness, and (3) a craniofacial anomaly (eg, cleft palate) associated with permanent hearing loss.5,15 Ninety-one of the 169 true cases (54%) had ≥1 of these risk factors, which is similar to published estimates.5,15 The proportion of high-risk infants of all permanent bilateral hearing loss cases is in line with Davis and Wood15 and Fortnum and Davis5; approximately 60% of all congenitally impaired children had ≥1 risk factors. However, there may be a shift toward the increase in the proportion of NICU infants, with 44% in this cohort as opposed to 29% found in both previously mentioned studies. The proportion with a family history of permanent childhood deafness was just 19%, which may reflect the complexity of history-taking at such an early stage. Craniofacial anomalies were present in 9%, which is between the 4% reported by Davis and Wood15 and the 12% reported by Fortnum and Davis.5 The high proportion of cases with risk factors led, in the early 1990s, to the widespread introduction of "at-risk" newborn screening in which attempts were made to screen all those infants (just under 10% of the birth cohort) with risk factors. However, in practice, as a result of the difficulty obtaining accurate risk status,6,16 the proportion of the target population identified by at-risk screening was rarely >40%. Therefore, it is unsafe to assume that all these 91 infants with risk indicators identified with hearing loss would have been found through targeted newborn hearing screening.

The median age of identification for those screened neonatally has been shown in research studies to be of the order of 2 months.1618 The findings from this evaluation of the first phase of a population-based national program are in line with that; the median age of identification was 10 weeks. Although this applies only to the limited cohort and does not take into consideration potential screen false-negatives or infants who missed the screen, compared with the situation before the introduction of screening, when the median age at identification of bilateral permanent hearing loss in the United Kingdom was 26 months,5 this is a massive improvement.

Importantly, given that intervention has been argued to be beneficial for degrees of hearing loss down to at least moderate levels,9 age at identification was independent of the degree of hearing loss. This was not the case before the introduction of NHSPs.

Before the introduction of newborn hearing screening, NICU infants with hearing loss were identified earlier.9 In the current evaluation, infants from the healthy infant population were identified significantly earlier than those from NICU. When there were delays in identification, these were often the result of assessment and service difficulties in the well-infant population, whereas in NICU infants, the delay was more likely to be associated with the health of the infant. Also, it is important to point out in the present analysis, chronologic ages were compared instead of corrected ages and that is likely to add to the difference between the outcome measures in the 2 nursery types.

Median age of enrollment in the early support program is of course strongly correlated with the age of identification of hearing loss, because according to the quality standards,17 all children who are identified with bilateral moderate or greater hearing loss should be reported to education services within 1 working day of identification.

The median age at hearing aid fitting of 16 weeks was similar to that reported elsewhere.1820 This is a significant improvement compared with the average age of 32 months in the United Kingdom before the implementation of newborn hearing screening.5 Of course, a few screen false-negatives may yet be identified, and not all subjects identified had hearing aids fitted; therefore, this median age may therefore change, but it is unlikely to be by a significant amount.

For the whole cohort, age at hearing aid fitting is the first event in which degree of hearing loss has an effect; infants with moderate hearing loss are fitted with hearing aids significantly later than those with severe or profound hearing loss; possible reasons are parental reticence (and the exercise of parental choice) in the light of some auditory responsiveness and assessment uncertainty. For NICU infants, those with profound (as well as moderate) hearing loss are fitted significantly later than those with severe hearing loss, presumably as a result of other difficulties.


    CONCLUSIONS
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
It is important to verify that screening programs that have been shown to be efficacious in research studies do indeed function effectively in routine service practice. This study reports on the effectiveness of the first phase of the newborn NHSP in England. This is a population-based national screen that aims to cover the full birth population to identify moderate or greater bilateral permanent hearing loss as early as possible. Analyses of 169 cases reported from 23 first phase sites and based on 170000 infants screened shows that the age markers chosen all occurred within the first few weeks and months of age. The descriptive statistics of the cases suggested that there are unlikely to be significant numbers of false-negatives or missed cases, and that in the main the profile of the cases was as expected; the possibility that the proportion of subjects with profound hearing loss is on the increase as a result of developments in the NICU practice merits additional investigation. A key feature of the NHSP program in England is the extent of planned and centrally funded implementation and "top-down" direction (involving, eg, a national IT screening management system, national training for screeners, preferred practice guidelines, and so on). It is highly likely that the positive outcomes reported here are closely linked to this public health approach to population-based screening.


    ACKNOWLEDGMENTS
 
This work was undertaken by the evaluation team for the implementation of newborn hearing screening program in England; the evaluation was funded by the Department of Health.

We thank Professor Adrian Davis and his team, as well as everybody in the local screening teams from all 23 first-phase newborn hearing screening program sites, particularly the staff from pediatric audiology services.


    FOOTNOTES
 
Accepted Nov 10, 2005.

Address correspondence to Kai Uus, MD, PhD, Audiology and Deafness Research Group, Humanities Building, Devas Street, School of Psychological Sciences, Faculty of Medical and Human Sciences, University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom. E-mail: kai.uus{at}manchester.ac.uk

The views expressed in the publication are those of the authors and not necessarily those of the Department of Health.

The authors have indicated they have no financial relationships relevant to this article to disclose.


    REFERENCES
 TOP
 ABSTRACT
 METHODS
 RESULTS
 DISCUSSION
 CONCLUSIONS
 REFERENCES
 
1. Fortnum HM, Summerfield AQ, Marshall DH, Davis AC, Bamford JM. Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ. 2001;323 :536 –539[Abstract/Free Full Text]

2. Yoshinaga-Itano C, Sedey AL, Coulter DK, Mehl AL. Language of early- and later-identified children with hearing loss. Pediatrics. 1998;102 :1161 –1171[Abstract/Free Full Text]

3. Thompson DC, McPhillips H, Davis R, Lieu T, Homer C, Helfand M. Universal Newborn Hearing Screening. Summary of evidence. JAMA. 2001;286 :2000 –2010[Abstract/Free Full Text]

4. Hyde ML. Evidence-based practice, ethics and EHDI program quality. In: Seewald RC, Bamford J, eds. A Sound Foundation Through Early Amplification (Proceedings of the 3rd International Pediatric Conference). Basel, Switzerland: Phonak AG; 2005

5. Fortnum H, Davis A. Epidemiology of permanent hearing impairment in Trent region, 1985–1993. Br J Audiol. 1997;31 :409 –446[Web of Science][Medline]

6. Vohr BR, Carty LM, Moore PE, Letourneau K. The Rhode Island hearing assessment program: experience with statewide hearing screening (1993–1996). J Pediatr. 1998;133 :353 –357[CrossRef][Web of Science][Medline]

7. Parving A, Hauch AM, Christensen B. Hearing loss in children: epidemiology, age at identification and causes through 30 years [in Danish]. Ugeskr Laeger. 2003;165 :574 –579[Medline]

8. Deben K, Janssens de Varebeke S, Cox T, Van de Heyning P. Epidemiology of hearing impairment at three Flemish Institutes for Deaf and Speech Defective Children. Int J Pediatr Otorhinolaryngol. 2003;67 :969 –975[CrossRef][Web of Science][Medline]

9. Davis A, Bamford J, Wilson I, Ramkalawan T, Forsaw M, Wright S. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess. 1997;1 :i –iv, 1–176.[Medline]

10. Wilson JMG, Junger G. Principles and Practice of Screening for Disease. Geneva, Switzerland: World Health Organization; 1968

11. Davis A, Hind S. The newborn hearing screening programme in England. Int J Pediatr Otorhinolaryngol. 2003;67 :S193 –196[Medline]

12. Newborn hearing screening programme. Audiology protocols (10 screens). Available at: www.nhsp.info/cms.php?folder=21. Accessed February 4, 2005

13. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Hear. 1999;20 :238 –252[CrossRef][Web of Science][Medline]

14. Sininger YS. Identification of auditory neuropathy in infants and children. Semin Hear. 2002;23 :193 –200[CrossRef]

15. Davis A, Wood, S. The epidemiology of childhood hearing impairment: factors relevant to planning services. Br J Audiol. 1992;26 :77 –90[Medline]

16. Watkin P. Neonatal otoacoustic emission screening and the identification of deafness. Arch Dis Child. 1996;74 :16 –25

17. Quality Standards in Paediatric Audiology. Vol IV. London, United Kingdom: National Deaf Children's Society; 2000

18. Harrison M, Roush J, Wallace J. Trends in age of identification and intervention in infants with hearing loss. Ear Hear. 2003;24 :89 –95[CrossRef][Medline]

19. Dalzell L, Orlando M, MacDonald M, et al. The New York State universal newborn hearing screening demonstration project: ages of hearing loss identification, hearing aid fitting, and enrollment in early intervention. Ear Hear. 2000;21 :118 –130[CrossRef][Web of Science][Medline]

20. Yoshinaga-Itano C. Early intervention after universal neonatal hearing screening: impact on outcomes. Ment Retard Dev Disabil Res Rev. 2003;9 :252 –266[CrossRef][Web of Science][Medline]


PEDIATRICS (ISSN 1098-4275). ©2006 by the American Academy of Pediatrics

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AJAHome page
L. A. Krishnan
Universal Newborn Hearing Screening Follow-Up: A University Clinic Perspective
Am J Audiol, December 1, 2009; 18(2): 89 - 98.
[Abstract] [Full Text] [PDF]


Home page
AJAHome page
M. P. Moeller, B. Hoover, B. Peterson, and P. Stelmachowicz
Consistency of Hearing Aid Use in Infants With Early-Identified Hearing Loss
Am J Audiol, June 1, 2009; 18(1): 14 - 23.
[Abstract] [Full Text] [PDF]


Home page
AJAHome page
L. Spivak, H. Sokol, C. Auerbach, and S. Gershkovich
Newborn Hearing Screening Follow-Up: Factors Affecting Hearing Aid Fitting by 6 Months of Age
Am J Audiol, June 1, 2009; 18(1): 24 - 33.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
D C McCann, S Worsfold, C M Law, M Mullee, S Petrou, J Stevenson, H M Yuen, and C R Kennedy
Reading and communication skills after universal newborn screening for permanent childhood hearing impairment
Arch. Dis. Child., April 1, 2009; 94(4): 293 - 297.
[Abstract] [Full Text] [PDF]


Home page
J Med ScreenHome page
K. W Chang, T J O-Lee, and M. Price
Evaluation of unilateral referrals on neonatal hearing screening
J Med Screen, March 1, 2009; 16(1): 17 - 21.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uus, K.
Right arrow Articles by Bamford, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uus, K.
Right arrow Articles by Bamford, J.
Related Collections
Right arrow Dentistry & Otolaryngology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?